ARYA Sciences Acquisition Corp IV

ARYA Sciences Acquisition Corp IV, trading under the ticker ARYD, is a blank-check company in the healthcare and life sciences sector sponsored by ARYA Sciences Holdings IV LLC, an affiliate of Perceptive Advisors, the New York-based healthcare-focused investment manager led by Joseph Edelman. The company completed its IPO in 2021 and filed a Form S-4 registration statement with the SEC on November 1, 2021, accession number 0001140361-21-036018, indicating a pending business combination requiring shareholder approval. ARYA Sciences is a multi-vehicle SPAC program that has consistently targeted biotechnology and life sciences opportunities. For the complete deal timeline, target company details, and current status of ARYD, sign up for full data access at SpacDesk.